Legal Opinion
Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.
Court of Appeals for the Federal Circuit
Decided August 3, 2012No. 2012-1062, 2012-1103, 2012-1104PublishedCited by 33 opinions
1Opinion of the Court
MOORE, Circuit Judge.
Amphastar Pharmaceuticals, Inc., International Medication Systems, Ltd., Watson Pharmaceuticals, Inc., and Watson Pharma., Inc. (collectively, Amphastar) appeal the district court’s order denying the Emergency Motion to Dissolve or Stay the preliminary injunction entered in this case. Because the district court applied an unduly narrow interpretation of the HatchWaxman safe harbor, 35 U.S.C. § 271(e)(1), we vacate the grant of a preliminary injunction and remand for further proceedings consistent with this opinion.
Background
This case is a patent litigation involving a…
2Cases cited13 opinions
- United States v. Ron Pair Enterprises, Inc.Supreme Court of the United States · 1989
- Robinson v. Shell Oil Co.Supreme Court of the United States · 1997
- Reiter v. Sonotone Corp.Supreme Court of the United States · 1979
- Barnhart v. Sigmon Coal Co.Supreme Court of the United States · 2002
- Reiter v. Sonotone Corp.Supreme Court of the United States · 1979
8 more not listed; retrieve them via the Exa API.
3Cited by33 opinions
- Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA Inc.Court of Appeals for the Federal Circuit · 2015
- Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2015
- FirstLine Transportation Security, Inc. v. United StatesUnited States Court of Federal Claims · 2012
- Amphastar Pharmaceuticals Inc. v. Momenta Pharmaceuticals, Inc.Court of Appeals for the First Circuit · 2017
- Classen Immunotherapies, Inc. v. King Pharmaceuticals, Inc.District Court, D. Maryland · 2013
28 more not listed; retrieve them via the Exa API.